MY ACCOUNT | NEWSLETTER |

More than half of dogs with osteoarthritis are overweight or obese

It is more important than ever that veterinarians work closely with owners to develop effective weight reduction and management programs.


One of the most concerning health trends in the United States (USA) is the number of overweight dogs, a growing epidemic that has been associated with a dramatic increase in a wide range of health problems. According to a 2018 report, 56% of dogs in the US are overweight.

Being overweight considerably increases the risk of osteoarthritis

These extra pounds of weight can put significant stress and strain on the joints, leading to the development of arthritis. In fact, according to one of the largest veterinary hospital networks in the country, the number of overweight dogs has increased 66% in the last 10 years; US Today, 52% of dogs ave been found diagnosed with osteoarthritis (OA) are overweight or obese. Nationally, 6.1% of all dogs and more than 20% of dogs 10 years and older suffer from OA.

While much progress has been made in developing pain relievers to help OA patients, it appears that much less emphasis has been placed on addressing the nutritional aspect that is often associated with this painful condition. Specifically, consuming excess calories plays an integral role in weight gain. In dogs, it has been shown that being overweight is clearly related to an increased risk of developing OA.

Collaboration between veterinarians and owners is essential

As such, it is more important than ever for veterinarians to work closely with pet owners to identify overweight or obese patients and develop effective weight reduction and management programs that help ensure that there is a proper balance between caloric intake and regular exercise. Given a large amount of highly palatable commercial dog foods and snacks, along with table scraps, it is very easy for dogs to gain weight steadily and stealthily.

Canine OA: Why counting calories isn’t just for humans. Albert Ahn, DVM. Veterinary Practice News.

Like1
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Zoetis is Redefining the Feline Veterinary Experience with the Commercial Launch of Bonqat® (pregabalin oral solution) in the U.S.

Like0
Dislike0

Spatio-temporal patterns of tick-borne disease diagnoses in Indiana, USA (2009–2018)

Like0
Dislike0

Abdominal ultrasonographic findings of cats with feline infectious peritonitis: an update

Like0
Dislike0

Pseudohyperkalemia in horses with rhabdomyolysis reported by an enzymatic chemistry analyzer

Like0
Dislike0

Retrospective evaluation of prognosis and survival with various immunosuppressants in 82 dogs diagnosed with meningoencephalitis of unknown etiology (2010-2021).

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2024 - All Rights Reserved
ISSN 2768-198X

Top